The successful treatment of certain autoimmune conditions with the humanized anti–IL-6 receptor (IL-6R) antibody tocilizumab has emphasized the clinical importance of cytokines that signal through the β-receptor subunit glycoprotein 130 (gp130). In this Review, we explore how gp130 signaling controls disease progression and examine why IL-6 has a special role among these cytokines as an inflammatory regulator. Attention will be given to the role of the soluble IL-6R, and we will provide a perspective into the clinical blockade of IL-6 activity in autoimmunity, inflammation, and cancer.
Simon A. Jones, Jürgen Scheller, Stefan Rose-John
Title and authors | Publication | Year |
---|---|---|
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
Y He, S Hwang, YA Ahmed, D Feng, N Li, M Ribeiro, F Lafdil, T Kisseleva, G Szabo, B Gao |
Cellular and Molecular Immunology | 2020 |
Treatments for COVID-19: emerging drugs against the coronavirus
Francesco Potì, Cristina Pozzoli, Maristella Adami, Enzo Poli, Lucio G Costa |
Acta bio-medica : Atenei Parmensis | 2020 |
Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study
M Kohsari, MH Khadem-Ansari, Y Rasmi, H Sayyadi |
Asian Pacific Journal of Cancer Prevention | 2020 |
Overview of the STAT‑3 signaling pathway in cancer and the development of specific inhibitors (Review)
Y Gu, I Mohammad, Z Liu |
Oncology Letters | 2020 |
Targeting Signal 3 Extracellularly and Intracellularly in Graft-Versus-Host Disease
S Kim, P Reddy |
Frontiers in immunology | 2020 |
Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review
M Amaya-Montoya, A Pérez-Londoño, V Guatibonza-García, A Vargas-Villanueva, CO Mendivil |
Advances in Therapy | 2020 |
Ocular cytomegalovirus latency exacerbates the development of choroidal neovascularization
J Xu, X Liu, X Zhang, B Marshall, Z Dong, Y Liu, DG EspinosaHeidmann, M Zhang |
The Journal of Pathology | 2020 |
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells
Z Jiang, R Liao, J Lv, S Li, D Zheng, L Qin, D Wu, S Chen, Y Long, Q Wu, S Wang, S Lin, X Huang, Z Tang, P Shi, H Zhou, Q Liu, R Zhao, Y Li, Y Jie, W Wei, P Lai, X Du, S Cui, R Weinkove, P Liu, D Pei, Y Yao, P Li |
Leukemia | 2020 |
Advances in targeted therapy for malignant lymphoma
L Wang, W Qin, YJ Huo, X Li, Q Shi, JE Rasko, A Janin, WL Zhao |
Signal Transduction and Targeted Therapy | 2020 |
In vitro and in vivo pharmacokinetic characterization of LMT-28 as a novel small molecular interleukin-6 inhibitor
SH Ahn, TH Heo, HS Jun, Y Choi |
Asian-Australasian Journal of Animal Sciences | 2020 |
Effective treatment of severe COVID-19 patients with tocilizumab
X Xu, M Han, T Li, W Sun, D Wang, B Fu, Y Zhou, X Zheng, Y Yang, X Li, X Zhang, A Pan, H Wei |
Proceedings of the National Academy of Sciences | 2020 |
Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease
NS Dourado, C dos Santos Souza, MM de Almeida, AB da Silva, BL dos Santos, VD Silva, AM Assis, JS da Silva, DO Souza, M de Fatima Dias Costa, AM Butt, SL Costa |
Frontiers in aging neuroscience | 2020 |
SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc
G Magro |
2020 | |
HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling
Y Higuchi, J Yasunaga, Y Mitagami, H Tsukamoto, K Nakashima, K Ohshima, M Matsuoka |
Proceedings of the National Academy of Sciences | 2020 |
COVID-19 Drug Treatment in China
L Fan, S Jiang, X Yang, Z Wang, C Yang |
Current Pharmacology Reports | 2020 |
Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries
TS Ghosh, S Rampelli, IB Jeffery, A Santoro, M Neto, M Capri, E Giampieri, A Jennings, M Candela, S Turroni, EG Zoetendal, GD Hermes, C Elodie, N Meunier, CM Brugere, E Pujos-Guillot, AM Berendsen, LC Groot, EJ Feskins, J Kaluza, B Pietruszka, MJ Bielak, B Comte, M Maijo-Ferre, C Nicoletti, WM Vos, S Fairweather-Tait, A Cassidy, P Brigidi, C Franceschi, PW O'Toole |
Gut | 2020 |
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
G van Duijneveldt, MD Griffin, TL Putoczki |
Clinical Science | 2020 |
Biosensing Cytokine IL-6: A Comparative Analysis of Natural and Synthetic Receptors
E Alfinito, M Beccaria, M Ciccarese |
Biosensors | 2020 |
The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis
R Davies, J Williams, K Sime, HS Jin, C Thompson, L Jordan, D Lang, JP Halcox, E Ellins, GW Jones, SA Jones, S Rose-John, A Williams, E Choy |
Rheumatology | 2020 |
Multiphase Assembly of Small Molecule Microcrystalline Peptide Hydrogel Allows Immunomodulatory Combination Therapy for Long‐Term Heart Transplant Survival
P Majumder, Y Zhang, M Iglesias, L Fan, JA Kelley, C Andrews, N Patel, JR Stagno, BC Oh, GJ Furtmüller, CC Lai, YX Wang, G Brandacher, G Raimondi, JP Schneider |
Small (Weinheim an Der Bergstrasse, Germany) | 2020 |
Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations E Freitas, MA Rodrigues, T Torres |
Clinical, cosmetic and investigational dermatology | 2020 |
Association between cytokine profiles and lung injury in COVID-19 pneumonia
LD Chen, ZY Zhang, XJ Wei, YQ Cai, WZ Yao, MH Wang, QF Huang, XB Zhang |
Respiratory Research | 2020 |
Inhibiting IL-6 in COVID-19: we are not sure
PM Honore, LB Gutierrez, L Kugener, S Redant, R Attou, A Gallerani, DD Bels |
Critical Care | 2020 |
Interactions among Interleukin-6, C-Reactive Protein and Interleukin-6 (-174) G/C Polymorphism in the Pathogenesis of Crohn’s Disease and Ulcerative Colitis
B Takač |
ACTA CLIN CROAT | 2020 |
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study
S Fantone, G Tossetta, R Montironi, M Senzacqua, D Marzioni, R Mazzucchelli |
European Journal of Histochemistry : EJH | 2020 |
Super-enhancers modulate interleukin-6 expression and function in cancers.
Bao Y, Wu Y, Tao B, Sun R, Lin T, Zheng Y, Zhu X, Shen H, Chen W, Fan Y |
Translational cancer research | 2020 |
Thermoresponsive, hollow, degradable core-shell nanoparticles for intraarticular delivery of anti-inflammatory peptide
Deloney M, Smart K, Christiansen BA, Panitch A |
Journal of Controlled Release | 2020 |